Sanofi Genzyme Announces Recipients of 2016 Patient Advocacy Leadership (PAL) Awards
$85.4 Billion Monoclonal Antibodies (mAbs) Market Analysis By Source, By Type of Production, By Indication, By End-use And Segment Forecasts, 2013 - 2024 - Research and Markets
Sanofi and Boehringer Ingelheim Confirm Closing of Business Swap on January 1st 2017
Pompe Disease Treatment – Market Drivers and Forecasts by Technavio
A roundup of investment news.
Focusing on stocks with the most visible cash flows has been a winning strategy, and this screen can find them.
This screen finds stocks that would make it into Morningstar's Wide-Moat Focus strategy.
Who's in front heading 'round the bend?
Morningstar analysts see pharmaceuticals as 2010's hot zone for mergers and acquisitions.